InsiderTradr

Decipher Labs Limited (DECIPHER.BO)

BSE · INR · Healthcare · Drug Manufacturers - Specialty & Generic

₹5.05 (-2.88%) as of

Key statistics

Market cap
51.01M
EPS (TTM)
-3.02
Dividend yield
0.00%
52-week range
4.81 – 10.99
Beta
0.82
Revenue (TTM)
138.51M
Profit margin
-13.31%
Volume
4.36k

About Decipher Labs Limited

Decipher Labs Limited, together with its subsidiaries, manufactures, markets, sells, and trades in pharmaceutical drugs in India and internationally. It operates through two segments, Manufacturing and Trading of Pharmaceutical Drugs and Consultancy. The company offers branded and finished formulations, bulk drugs, and chemicals. It also provides information technology (IT) consultancy services comprising technology integration and systems consulting, software development consulting, and management of IT projects. In addition, the company offers ERP implementation, mobile and cloud solutions, product development, and offshore services. It serves formulators, manufacturers, and research and development agencies. The company was formerly known as Combat Drugs Limited and changed its name to Decipher Labs Limited in January 2020. Decipher Labs Limited was incorporated in 1986 and is based in Hyderabad, India.

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Headquarters
Hyderabad, India
Employees
1

decipherlabs.in

Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.

Related stocks